Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Matrajt

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Emerging Infectious Diseases|April 29, 2020
Evaluating the Effectiveness of Social Distancing Interventions to Delay or Flatten the Epidemic Curve of Coronavirus DiseaseLaura Matrajt, Tiffany Leung
Plos Neglected Tropical Diseases|May 20, 2021
Protection afforded by previous Vibrio cholerae infection against subsequent disease and infection: A reviewTiffany Leung, Laura Matrajt
Plos One|November 19, 2010
Optimizing vaccine allocation at different points in time during an epidemicLaura Matrajt, Ira M Longini
Epidemics|February 14, 2012
Critical immune and vaccination thresholds for determining multiple influenza epidemic wavesLaura Matrajt, Ira M Longini
Plos Neglected Tropical Diseases|April 20, 2022
Optimizing one-dose and two-dose cholera vaccine allocation in outbreak settings: A modeling studyTiffany Leung, Julia Eaton, Laura Matrajt
PNAS Nexus|May 8, 2023
Evaluation of mpox vaccine dose-sparing strategiesDobromir Dimitrov, Blythe Adamson, Laura Matrajt
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 15, 2019
Reply to Lindsey, Höschler, and de SilvaLaura Matrajt, M Elizabeth Halloran, Rustom Antia
PLOS Global Public Health|January 22, 2024
Covid19Vaxplorer: A free, online, user-friendly COVID-19 vaccine allocation comparison toolImelda Trejo, Pei-Yao Hung, Laura Matrajt
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Covid19Vaxplorer: a free, online, user-friendly COVID-19 Vaccine Allocation Comparison ToolImelda Trejo, Pei-Yao Hung, Laura Matrajt
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2019
Successes and Failures of the Live-attenuated Influenza Vaccine: Can We Do Better?Laura Matrajt, M Elizabeth Halloran, Rustom Antia
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Emerging Infectious Diseases|April 29, 2020
Evaluating the Effectiveness of Social Distancing Interventions to Delay or Flatten the Epidemic Curve of Coronavirus DiseaseLaura Matrajt, Tiffany Leung
Plos Neglected Tropical Diseases|May 20, 2021
Protection afforded by previous Vibrio cholerae infection against subsequent disease and infection: A reviewTiffany Leung, Laura Matrajt
Plos One|November 19, 2010
Optimizing vaccine allocation at different points in time during an epidemicLaura Matrajt, Ira M Longini
Epidemics|February 14, 2012
Critical immune and vaccination thresholds for determining multiple influenza epidemic wavesLaura Matrajt, Ira M Longini
Plos Neglected Tropical Diseases|April 20, 2022
Optimizing one-dose and two-dose cholera vaccine allocation in outbreak settings: A modeling studyTiffany Leung, Julia Eaton, Laura Matrajt
PNAS Nexus|May 8, 2023
Evaluation of mpox vaccine dose-sparing strategiesDobromir Dimitrov, Blythe Adamson, Laura Matrajt
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 15, 2019
Reply to Lindsey, Höschler, and de SilvaLaura Matrajt, M Elizabeth Halloran, Rustom Antia
PLOS Global Public Health|January 22, 2024
Covid19Vaxplorer: A free, online, user-friendly COVID-19 vaccine allocation comparison toolImelda Trejo, Pei-Yao Hung, Laura Matrajt
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Covid19Vaxplorer: a free, online, user-friendly COVID-19 Vaccine Allocation Comparison ToolImelda Trejo, Pei-Yao Hung, Laura Matrajt
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2019
Successes and Failures of the Live-attenuated Influenza Vaccine: Can We Do Better?Laura Matrajt, M Elizabeth Halloran, Rustom Antia
Pageof 5